Immutep Limited (ASX:IMM)
Australia · Delayed Price · Currency is AUD 0.3920
+0.0020 (0.51%)
Feb 26, 2026, 2:19 PM AEST
Immutep Market Cap
Immutep has a market cap or net worth of 574.75 million as of February 25, 2026. Its market cap has increased by 23.39% in one year.
Market Cap
574.75M
Enterprise Value
476.83M
Revenue
6.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.39
Market Cap Chart
Since August 29, 1996, Immutep's market cap has increased from 3.66M to 574.75M, an increase of 15,590.88%. That is a compound annual growth rate of 18.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 574.75M | -6.02% |
| Dec 31, 2025 | 611.59M | 15.11% |
| Dec 31, 2024 | 531.29M | 29.54% |
| Dec 29, 2023 | 410.15M | 69.62% |
| Dec 30, 2022 | 241.81M | -42.22% |
| Dec 31, 2021 | 418.52M | 55.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuren Pharmaceuticals | 1.66B |
| PYC Therapeutics | 1.41B |
| Clarity Pharmaceuticals | 1.31B |
| Opthea | 738.77M |
| Clinuvel Pharmaceuticals | 585.84M |
| Racura Oncology | 403.30M |
| Dimerix | 285.19M |
| Orthocell | 249.60M |